1
|
de Maar JS, Zandvliet MMJM, Veraa S, Tobón Restrepo M, Moonen CTW, Deckers R. Ultrasound and Microbubbles Mediated Bleomycin Delivery in Feline Oral Squamous Cell Carcinoma—An In Vivo Veterinary Study. Pharmaceutics 2023; 15:pharmaceutics15041166. [PMID: 37111651 PMCID: PMC10142092 DOI: 10.3390/pharmaceutics15041166] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Revised: 03/06/2023] [Accepted: 03/31/2023] [Indexed: 04/09/2023] Open
Abstract
To investigate the feasibility and tolerability of ultrasound and microbubbles (USMB)-enhanced chemotherapy delivery for head and neck cancer, we performed a veterinary trial in feline companion animals with oral squamous cell carcinomas. Six cats were treated with a combination of bleomycin and USMB therapy three times, using the Pulse Wave Doppler mode on a clinical ultrasound system and EMA/FDA approved microbubbles. They were evaluated for adverse events, quality of life, tumour response and survival. Furthermore, tumour perfusion was monitored before and after USMB therapy using contrast-enhanced ultrasound (CEUS). USMB treatments were feasible and well tolerated. Among 5 cats treated with optimized US settings, 3 had stable disease at first, but showed disease progression 5 or 11 weeks after first treatment. One cat had progressive disease one week after the first treatment session, maintaining a stable disease thereafter. Eventually, all cats except one showed progressive disease, but each survived longer than the median overall survival time of 44 days reported in literature. CEUS performed immediately before and after USMB therapy suggested an increase in tumour perfusion based on an increase in median area under the curve (AUC) in 6 out of 12 evaluated treatment sessions. In this small hypothesis-generating study, USMB plus chemotherapy was feasible and well-tolerated in a feline companion animal model and showed potential for enhancing tumour perfusion in order to increase drug delivery. This could be a forward step toward clinical translation of USMB therapy to human patients with a clinical need for locally enhanced treatment.
Collapse
Affiliation(s)
- Josanne S. de Maar
- Imaging and Oncology Division, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands
| | - Maurice M. J. M. Zandvliet
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands
| | - Stefanie Veraa
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands
| | - Mauricio Tobón Restrepo
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands
| | - Chrit T. W. Moonen
- Imaging and Oncology Division, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands
| | - Roel Deckers
- Imaging and Oncology Division, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands
| |
Collapse
|
2
|
Novickij V, Rembiałkowska N, Szlasa W, Kulbacka J. Does the shape of the electric pulse matter in electroporation? Front Oncol 2022; 12:958128. [PMID: 36185267 PMCID: PMC9518825 DOI: 10.3389/fonc.2022.958128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 08/15/2022] [Indexed: 11/13/2022] Open
Abstract
Electric pulses are widely used in biology, medicine, industry, and food processing. Numerous studies indicate that electroporation (EP) is a pulse-dependent process, and the electric pulse shape and duration strongly determine permeabilization efficacy. EP protocols are precisely planned in terms of the size and charge of the molecules, which will be delivered to the cell. In reversible and irreversible EP applications, rectangular or sine, polar or bipolar pulses are commonly used. The usage of pulses of the asymmetric shape is still limited to high voltage and low voltage (HV/LV) sequences in the context of gene delivery, while EP-based applications of ultra-short asymmetric pulses are just starting to emerge. This review emphasizes the importance and role of the pulse shape for membrane permeabilization by EP.
Collapse
Affiliation(s)
- Vitalij Novickij
- Faculty of Electronics, Vilnius Gediminas Technical University (Vilnius TECH), Vilnius, Lithuania
- *Correspondence: Vitalij Novickij, ; Julita Kulbacka,
| | - Nina Rembiałkowska
- Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland
| | - Wojciech Szlasa
- Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
| | - Julita Kulbacka
- Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland
- *Correspondence: Vitalij Novickij, ; Julita Kulbacka,
| |
Collapse
|
3
|
Electroporation, electrochemotherapy and electro-assisted drug delivery in cancer. A state-of-the-art review. Biophys Chem 2022; 286:106819. [DOI: 10.1016/j.bpc.2022.106819] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Revised: 04/06/2022] [Accepted: 04/12/2022] [Indexed: 01/08/2023]
|
4
|
Mansourian M, Firoozabadi SMP, Hassan ZM. The investigation of Pulse-Modulated GSM-900 MHz electromagnetic field effects on the electrochemotherapy mechanisms in vivo. Electromagn Biol Med 2021; 41:71-79. [PMID: 34839760 DOI: 10.1080/15368378.2021.2006689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Electrochemotherapy (ECT) as a tumor treatment modality is approved for cutaneous and subcutaneous tumors. The purpose of the present study was to examine the effect of 900 MHz radiofrequency (RF) pulse-modulated by 217 Hz EMFs similar to those emitted by mobile phones on the mechanisms of ECT in vivo including: tumor hypoxia and immune system response, and on tumor volume.4 T1 cells were injected subcutaneously into the right flank of Balb/c mice. The mice were exposed to RF fields at specific absorption rate (SAR) 2 W/kg for 10 min/day and then treated with ECT. Two protocols of ECT were used: ((70 V/cm-5 kHz) and 70 V/cm-4 kHz)). Tumor hypoxia was analyzed through HIF-1α immuonohistochemistry assay. Interleukin 4 (IL-4) and IFN-γ levels were estimated by enzyme-linked immunosorbent assay (ELISA) technique to evaluate immune system response. Also, tumors volume changes were measured for 24 days following the treatment. The results showed that pulse-modulated RF fields could increase hypoxia induced by ECT, significantly (about 13% in ECT (70 V/cm-5 kHz) and 11% in ECT (70 V/cm-4 kHz)). However, these fields did not have significant effect on immune system response (the levels of IL-4 and IFN-γ) and tumor volume changes induced by ECT. Our results indicated that pulse-modulated RF fields could not affect tumor volume changes in ECT with the frequency of 5 kHz and voltage of 70 V/cm efficacy in vivo. However, investigating the role of other environmental intervening factors on this protocol of ECT is recommended in further studies.
Collapse
Affiliation(s)
- Mahsa Mansourian
- Department of Medical Physics, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
| | - S M P Firoozabadi
- Biomedical Engineering, Department of Medical Physics, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
| | - Zuhair Mohammad Hassan
- Immunonology, Department of Immunology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
| |
Collapse
|
5
|
Nikolova B, Semkova S, Tsoneva I, Antov G, Ivanova J, Vasileva I, Kardaleva P, Stoineva I, Christova N, Nacheva L, Kabaivanova L. Characterization and potential antitumor effect of a heteropolysaccharide produced by the red alga Porphyridium sordidum. Eng Life Sci 2019; 19:978-985. [PMID: 32624987 PMCID: PMC6999067 DOI: 10.1002/elsc.201900019] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Revised: 04/25/2019] [Accepted: 07/01/2019] [Indexed: 01/18/2023] Open
Abstract
Taking into account the rising trend of the incidence of cancers of various organs, effective therapies are urgently needed to control human malignancies. However, almost all chemotherapy drugs currently on the market cause serious side effects. Fortunately, several studies have shown that some non-toxic biological macromolecules, including algal polysaccharides, possess anti-cancer activities or can increase the efficacy of conventional chemotherapy drugs. Polysaccharides are characteristic secondary metabolites of many algae. The efficacy of polysaccharides on the normal and cancer cells is not well investigated, but our investigations proved a cell specific effect of a newly isolated extracellular polysaccharide from the red microalga Porphyridium sordidum. The investigated substance was composed of xylose:glucose and galactose:manose:rhamnose in a molar ratio of 1:0.52:0.44:0.31. Reversible electroporation has been exploited to increase the transport through the plasma membrane into the tested breast cancer tumor cells MCF-7 and MDA-MB231. Application of 75 µg/mL polysaccharide in combination with 200 V/cm electroporation induced 40% decrease in viability of MDA-MB231 cells and changes in cell morphology while control cells (MCF10A) remained with normal morphology and kept vitality.
Collapse
Affiliation(s)
- Biliana Nikolova
- Institute of Biophysics and Biomedical EngineeringBulgarian Academy of SciencesSofiaBulgaria
| | - Severina Semkova
- Institute of Biophysics and Biomedical EngineeringBulgarian Academy of SciencesSofiaBulgaria
| | - Iana Tsoneva
- Institute of Biophysics and Biomedical EngineeringBulgarian Academy of SciencesSofiaBulgaria
| | - Georgi Antov
- Institute of Biophysics and Biomedical EngineeringBulgarian Academy of SciencesSofiaBulgaria
| | - Juliana Ivanova
- Institute of Plant Physiology and GeneticsBulgarian Academy of SciencesSofiaBulgaria
| | - Ivanina Vasileva
- Institute of Plant Physiology and GeneticsBulgarian Academy of SciencesSofiaBulgaria
| | - Proletina Kardaleva
- Institute of Organic Chemistry with Centre of PhytochemistryBulgarian Academy of SciencesSofiaBulgaria
| | - Ivanka Stoineva
- Institute of Organic Chemistry with Centre of PhytochemistryBulgarian Academy of SciencesSofiaBulgaria
| | - Nelly Christova
- The Stephan Angeloff Institute of MicrobiologyBulgarian Academy of SciencesSofiaBulgaria
| | - Lilyana Nacheva
- The Stephan Angeloff Institute of MicrobiologyBulgarian Academy of SciencesSofiaBulgaria
| | - Lyudmila Kabaivanova
- The Stephan Angeloff Institute of MicrobiologyBulgarian Academy of SciencesSofiaBulgaria
| |
Collapse
|
6
|
Passive and electro-assisted delivery of hydrogel nanoparticles in solid tumors, visualized by optical and magnetic resonance imaging in vivo. Anal Bioanal Chem 2015; 408:905-14. [DOI: 10.1007/s00216-015-9182-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2015] [Revised: 11/02/2015] [Accepted: 11/09/2015] [Indexed: 10/22/2022]
|
7
|
Spugnini EP, Pizzuto M, Filipponi M, Romani L, Vincenzi B, Menicagli F, Lanza A, De Girolamo R, Lomonaco R, Fanciulli M, Spriano G, Baldi A. Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head. J Vet Intern Med 2015; 29:1368-75. [PMID: 26192904 PMCID: PMC4858043 DOI: 10.1111/jvim.13586] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2014] [Revised: 05/26/2015] [Accepted: 06/24/2015] [Indexed: 12/17/2022] Open
Abstract
Background Advanced carcinoma of the head represents a substantial health problem in cats for local control and overall survival. Objectives Evaluate the capability of electrochemotherapy (ECT) to improve bleomycin efficacy in cats with periocular carcinoma and advanced carcinoma of the head. Animals Twenty‐one cats with periocular carcinoma (17 squamous cell carcinoma [SCC] and 4 anaplastic carcinoma) and 26 cats with advanced SCC of the head. Methods Nonrandomized prospective controlled study. Periocular carcinoma cohorts: 12 cats were treated with bleomycin (15 mg/m2IV) coupled with ECT under anesthesia; 9 cats were treated with bleomycin alone. Advanced head SCC cohorts: 14 cats were treated with bleomycin (15 mg/m2IV) coupled with ECT administered under sedation; 12 control cats were treated with bleomycin alone. ECT treatments (2–8) were performed every other week until complete remission (CR) or tumor progression occurred. Results Toxicities were minimal and mostly treated symptomatically. Overall response rate in the ECT treated animals was 89% (21 Complete Response [CR] and 2 Partial Response [PR]) whereas controls had response rate of 33% (4 CR and 3 PR). Median time to progression in ECT group was 30.5 months, whereas in controls it was 3.9 months (P < .0001). Median time to progression for ECT cohorts was 24.2 months for periocular cohort and 20.6 in advanced head SCC cohort, respectively. Conclusions Electrochemotherapy is well tolerated for advanced SCC of the head in cats; its use may be considered among loco‐regional strategies for cancer therapy in sensitive body regions such as periocular region.
Collapse
Affiliation(s)
- E P Spugnini
- SAFU, Regina Elena Cancer Institute, Rome, Italy
| | - M Pizzuto
- Centro Veterinario Gianicolense, Rome, Italy
| | - M Filipponi
- Centro Veterinario Casal Monastero, Rome, Italy
| | - L Romani
- Centro Veterinario Casal Monastero, Rome, Italy
| | - B Vincenzi
- Medical Oncology, University Campus Bio-Medico, Rome, Italy
| | - F Menicagli
- Centro Veterinario Gianicolense, Rome, Italy
| | - A Lanza
- Centro Veterinario Gianicolense, Rome, Italy
| | | | - R Lomonaco
- Ambulatorio Veterinario Dr. Lomonaco, Rome, Italy
| | - M Fanciulli
- SAFU, Regina Elena Cancer Institute, Rome, Italy
| | - G Spriano
- Department of Head and Neck Oncology, Regina Elena Cancer Institute, Rome, Italy
| | - A Baldi
- Department of Environmental Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, Naples, Italy
| |
Collapse
|
8
|
Nikolova B, Kostadinova A, Dimitrov B, Zhelev Z, Bakalova R, Aoki I, Saga T, Tsoneva I. Fluorescent imaging for assessment of the effect of combined application of electroporation and rifampicin on HaCaT cells as a new therapeutic approach for psoriasis. SENSORS 2013; 13:3625-34. [PMID: 23493125 PMCID: PMC3658765 DOI: 10.3390/s130303625] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/11/2013] [Revised: 02/13/2013] [Accepted: 03/06/2013] [Indexed: 11/26/2022]
Abstract
The study aimed to clarify the role of electric pulses in combination with chemotherapy on the viability of keratinocyte cell line HaCaT, in the context of its application as a new therapeutic approach for psoriasis. The data show that electroporation of HaCaT cells in combination with rifampicin induces cytoskeleton disruption and increases permeability of cell monolayer due to cell-cell junctions' interruption, visualized by fluorescent imaging of E-cadherin and actin integrity. This was accompanied with synergistic reduction of cell viability. The study proposes a new opportunity for more effective skin treatment than chemotherapy. The future application of this electrochemotherapeutic approach for combined local treatment of psoriasis may have serous benefits because of a high possibility to avoid side-effects of conventional chemotherapy.
Collapse
Affiliation(s)
- Biliana Nikolova
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad.G. Bonchev Str., bl. 21, Sofia 1113, Bulgaria; E-Mails: (B.N.); (A.K.); (B.D.); (Z.Z.); (I.T.)
| | - Anelia Kostadinova
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad.G. Bonchev Str., bl. 21, Sofia 1113, Bulgaria; E-Mails: (B.N.); (A.K.); (B.D.); (Z.Z.); (I.T.)
| | - Borislav Dimitrov
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad.G. Bonchev Str., bl. 21, Sofia 1113, Bulgaria; E-Mails: (B.N.); (A.K.); (B.D.); (Z.Z.); (I.T.)
| | - Zhivko Zhelev
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad.G. Bonchev Str., bl. 21, Sofia 1113, Bulgaria; E-Mails: (B.N.); (A.K.); (B.D.); (Z.Z.); (I.T.)
- Medical Faculty, Trakia University, 11 Armeiska Str., Stara Zagora 6000, Bulgaria
| | - Rumiana Bakalova
- Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; E-Mails: (I.A.); (T.S.)
- Medical Faculty, Sofia University, 1 Koziak Str., Sofia 1407, Bulgaria
- Author to whom correspondence should be addressed; E-Mail: ; Tel.: +81-42-206-3274; Fax: +81-42-206-9470
| | - Ichio Aoki
- Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; E-Mails: (I.A.); (T.S.)
| | - Tsuneo Saga
- Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; E-Mails: (I.A.); (T.S.)
| | - Iana Tsoneva
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad.G. Bonchev Str., bl. 21, Sofia 1113, Bulgaria; E-Mails: (B.N.); (A.K.); (B.D.); (Z.Z.); (I.T.)
| |
Collapse
|